Inventor
CIPOLLA DAVID C
US19 patents
⚠️ This page may combine multiple inventors who share the name “CIPOLLA DAVID C”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ARADIGM CORP
8 patentsUS9259424B2Feb 16, 2016
Concentrated, inhalable antibiotic formulation
ARADIGM CORP25 citations97
US9078897B1Jul 14, 2015
Concentrated, inhalable antibiotic formulation
ARADIGM CORP26 citations95
US9987227B2Jun 5, 2018
Inhaled surfactant-modified liposomal formulations providing both an immediate and sustained release profile
ARADIGM CORP2 citations73
US9844548B2Dec 19, 2017
Liposomal ciprofloxacin formulations with encapsulated ciprofloxacin nanocrystals
ARADIGM CORP3 citations73
US9968555B2May 15, 2018
Liposomal formulations that form drug nanocrystals after freeze-thaw
ARADIGM CORP0 citations52
US10420765B2Sep 24, 2019
Concentrated, inhalable ciprofloxacin formulation
ARADIGM CORP0 citations51
US10376508B2Aug 13, 2019
Liposomal ciprofloxacin formulations with activity against non-tuberculous mycobacteria
ARADIGM CORP0 citations49
US9532986B2Jan 3, 2017
Liposomal ciprofloxacin formulations with activity against non-tuberculous mycobacteria
ARADIGM CORP0 citations49
CIPOLLA DAVID C
6 patentsUS8268347B1Sep 18, 2012
Dual action, inhaled formulations providing both an immediate and sustained release profile
CIPOLLA DAVID C47 citations97
US8119156B2Feb 21, 2012
Dual action, inhaled formulations providing both an immediate and sustained release profile
CIPOLLA DAVID C40 citations97
US8414915B2Apr 9, 2013
Dual action, inhaled formulations providing both an immediate and sustained release profile
CIPOLLA DAVID C42 citations93
US9028864B2May 12, 2015
Concentrated, inhalable antibiotic formulation
CIPOLLA DAVID C25 citations92
US8071127B2Dec 6, 2011
Dual action, inhaled formulations providing both an immediate and sustained release profile
CIPOLLA DAVID C42 citations92
US9545401B2Jan 17, 2017
Concentrated, inhalable ciprofloxacin formulation
CIPOLLA DAVID C3 citations83